HUP0001263A3 - Methods of therapeutic administration of anti-cd4ol compounds - Google Patents

Methods of therapeutic administration of anti-cd4ol compounds

Info

Publication number
HUP0001263A3
HUP0001263A3 HU0001263A HUP0001263A HUP0001263A3 HU P0001263 A3 HUP0001263 A3 HU P0001263A3 HU 0001263 A HU0001263 A HU 0001263A HU P0001263 A HUP0001263 A HU P0001263A HU P0001263 A3 HUP0001263 A3 HU P0001263A3
Authority
HU
Hungary
Prior art keywords
cd4ol
compounds
methods
therapeutic administration
therapeutic
Prior art date
Application number
HU0001263A
Other languages
English (en)
Original Assignee
Biogen Idec Ma Inc Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Ma Inc Cambridge filed Critical Biogen Idec Ma Inc Cambridge
Publication of HUP0001263A2 publication Critical patent/HUP0001263A2/hu
Publication of HUP0001263A3 publication Critical patent/HUP0001263A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0001263A 1997-03-07 1998-01-09 Methods of therapeutic administration of anti-cd4ol compounds HUP0001263A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4015497P 1997-03-07 1997-03-07

Publications (2)

Publication Number Publication Date
HUP0001263A2 HUP0001263A2 (hu) 2000-08-28
HUP0001263A3 true HUP0001263A3 (en) 2005-11-28

Family

ID=21909414

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001263A HUP0001263A3 (en) 1997-03-07 1998-01-09 Methods of therapeutic administration of anti-cd4ol compounds

Country Status (3)

Country Link
AU (1) AU5623398A (hu)
HU (1) HUP0001263A3 (hu)
WO (1) WO1998039026A2 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104684A0 (en) 1992-02-14 1993-06-10 Bristol Myers Squibb Co The cd40cr receptor and ligands therefor
CN100352497C (zh) * 1998-04-03 2007-12-05 达特茅斯学院理事 应用特异性结合cd40cr(cd40 配体)的抗体抑制体液免疫
WO2000072882A1 (fr) * 1999-06-01 2000-12-07 Eisai Co., Ltd. Agents prophylactiques du purpura thrombocytopenique idiopathique
EP1839674A1 (en) * 1999-10-04 2007-10-03 Novartis Vaccines and Diagnostics, Inc. CD40 antagonist for treating psoriasis
JP2003510371A (ja) * 1999-10-04 2003-03-18 カイロン コーポレイション 乾癬を処置するためのｃｄ４０アンタゴニスト
KR20020072277A (ko) * 1999-11-08 2002-09-14 아이덱 파마슈티칼즈 코포레이션 항-ｃｄ20 항체 및/또는 화학요법 및 방사선요법과결합하여 항-ｃｄ40ｌ 항체를 이용한 ｂ세포 악성종양의치료방법
EP1262194A4 (en) * 2000-03-06 2003-05-07 Eisai Co Ltd HEALING AND PREVENTIVE AGENTS FOR THE ANTIPHOSPHOLIPID-ANTIBODY SYNDROME
AU2001251612A1 (en) 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
EP1294699B1 (en) 2000-05-12 2016-04-13 Genzyme Corporation Modulators of tnf- alpha signalling
WO2001087310A1 (en) * 2000-05-18 2001-11-22 Biotransplant, Inc. Process for reducing antibody response against xenografts
AU8867501A (en) * 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
JP2004508420A (ja) * 2000-09-18 2004-03-18 アイデック　ファーマスーティカルズ　コーポレイション Ｂ細胞枯渇抗体／免疫調節性抗体の組合せを用いて自己免疫疾患を治療するための併用療法
DE60335652D1 (de) 2002-11-21 2011-02-17 Genzyme Corp Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung
JP4914008B2 (ja) 2002-11-21 2012-04-11 ジェンザイム・コーポレーション 免疫寛容を誘導するためのジアミド誘導体と免疫抑制剤との組み合わせ

Also Published As

Publication number Publication date
WO1998039026A2 (en) 1998-09-11
HUP0001263A2 (hu) 2000-08-28
AU5623398A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
ZA983176B (en) Therapeutic compounds
PL344977A1 (en) Therapeutic uses of quinoline derivatives
EP0831845A4 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS
GB2323531B (en) Therapeutic formulations
AP9600895A0 (en) Therapeutic compounds
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
PL327732A1 (en) Compounds of therapeutic activity
GB9700737D0 (en) Administration of drugs
GB9716345D0 (en) Therapeutic compounds
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
GB9716344D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9524942D0 (en) Drug therapy
PL325509A1 (en) Therapeutic agent for oral administration
GB9626450D0 (en) Therapeutic compounds
IL126778A0 (en) Administration of histamine for therapeutic purposes
GB9515060D0 (en) Therapeutic heterocyclic compounds
GB9705401D0 (en) Therapeutic compounds
GB9716111D0 (en) Therapeutic compounds
ZA97322B (en) Therapeutic use of d-threo-methylphenidate.
GB9523558D0 (en) Therapeutic compounds
GB9512868D0 (en) Therapeutic compounds
GB9526110D0 (en) Therapeutic compounds
GB9523801D0 (en) Therapeutic compounds